Back
Global Payments 10K Form
Buy
63
GPN
Global Payments
Last Price:
116.34
Seasonality Move:
6.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-31 | 10Q | GPN/Global Payments Quarterly |
2023-08-01 | 10Q | GPN/Global Payments Quarterly |
2023-05-03 | 10Q | GPN/Global Payments Quarterly |
2022-10-31 | 10Q | GPN/Global Payments Quarterly |
2022-08-01 | 10Q | GPN/Global Payments Quarterly |
2022-05-02 | 10Q | GPN/Global Payments Quarterly |
Receive GPN News And Ratings
See the #1 stock for the next 7 days that we like better than GPN
GPN Financial Statistics
Sales & Book Value
Annual Sales: | $9.65B |
---|---|
Cash Flow: | $1.56B |
Price / Cash Flow: | 10.35 |
Annual Sales: | $89.67 |
Price / Book: | 1.29 |
Profitability
EPS (TTM): | 5.31000 |
---|---|
Net Income (TTM): | $1.36B |
Gross Margin: | $5.93B |
Return on Equity: | 5.85% |
Return on Assets: | 2.71% |
Global Payments Earnings Forecast
Key Global Payments Financial Ratios
- The Gross Profit Margin over the past 24 years for GPN is 61.39%.
- The Selling, General & Administrative Expenses for GPN have been equal to 42.20% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 66.94% of Operating Income.
- The Net Earning history of GPN is 10.22% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 14 years.
Global Payments Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Financial Services |
Sector: | Financials |
Current Symbol: | GPN |
CUSIP: | 37940X |
Website: | globalpaymentsinc.com |
Debt
Debt-to-Equity Ratio: | 0.77 |
---|---|
Current Ratio: | 0.93 |
Quick Ratio: | 0.48 |
Price-to-Earnings
Trailing P/E Ratio: | 30.79 |
---|---|
Forward P/E Ratio: | 9.04 |
GPN Technical Analysis vs Fundamental Analysis
Buy
63
Global Payments (GPN)
is a Buy
Is Global Payments a Buy or a Sell?
-
Global Payments stock is rated a Buy
The current Global Payments [GPN] share price is $114.83. The Score for GPN is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.